RxDoctor Payments DataLook up a doctor →

Ronald Suh, MD

Urology · Avon, INNPI 1164436523

Payments from drug & device makers

$125,088in general payments, 2019–2025

Across 453 payments — averaging $276.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ferring Pharmaceuticals AS$38K
  • Ferring International Pharmascience Center US$20K
  • Sumitomo Pharma America, Inc.$20K
  • Pfizer$15K
  • Endo Pharmaceuticals Inc.$14K
  • Astellas Pharma Global Development$3K
  • plus $15K from 46 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Ferring Pharmaceuticals AS18$37,883
Ferring International Pharmascience Center US8$20,423
Sumitomo Pharma America, Inc.32$19,933
Pfizer54$14,847
Endo Pharmaceuticals Inc.35$14,244
Astellas Pharma Global Development2$3,150
Medivation LLC.4$2,820
Janssen Research & Development, LLC4$2,650
Avyxa Pharma, LLC1$1,000
Bayer31$996
Johnson & Johnson25$874
Astellas Pharma US Inc25$577
Dendreon Pharmaceuticals LLC12$509
Novartis12$410
Coloplast7$348
Myriad Genetic Laboratories, Inc.12$285
Ferring Pharmaceuticals Inc.7$263
AbbVie(2 entities)14$258
Amgen8$219
Sanofi5$215
Progenics Pharmaceuticals, Inc.6$214
Boston Scientific5$210
Accord Healthcare, Inc.8$191
Urogen Pharma, Inc.8$187
Verity Pharmaceuticals Inc.8$172
Janssen Scientific Affairs, LLC4$168
Blue Earth Diagnostics6$167
AstraZeneca(2 entities)5$167
Myovant Sciences Inc.7$161
Tolmar, Inc.20$156
Procept Biorobotics Corporation1$149
Sun Pharmaceutical Industries Inc.7$140
Merck6$132
Antares Pharma, Inc.9$128
Alnylam Pharmaceuticals Inc.6$128
Sanofi-aventis U.S. LLC2$108
Tolmar Pharmaceuticals, Inc.3$67
Medtronic(2 entities)3$65
Foundation Medicine, Inc.3$52
Acerus Pharmaceuticals Corporation3$49
Vertex2$47
Endo USA, Inc.2$45
Rochester Medical Corporation1$45
Urovant Sciences Inc2$45
Calyxo, Inc.2$40
C. R. Bard, Inc. & Subsidiaries1$35
Aytu Biopharma, Inc.2$32
Davol Inc.1$22
Koelis Inc.1$17
Kowa Pharmaceuticals America, Inc.1$17
Laborie Medical Technologies Corp.1$13
Neotract Inc.1$12

How this compares

$125,088 in reported general payments places this provider in the 95th percentile of 272 urology providers in Indiana.

See all urology providers in Indiana →

Medicare billing

Part B allowed, 2024
$185,531
Medicare patients
534
Services billed
4,980

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Avon

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →